Clinical features and management of poisoning due to antimalarial drugs.
about
Amrinone for refractory cardiogenic shock following chloroquine poisoningThe pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.Delayed therapeutic hypothermia following cardiac arrest secondary to chloroquine toxicityBone marrow aplasia following acute poisoning with chloroquine-proguanil.Antimalarial agents: specific chemoprophylaxis regimens.Novel Therapies for Myocardial Irritability following Extreme Hydroxychloroquine Toxicity.Assessment of safety of the major antimalarial drugs.Long-term administration of artesunate induces reproductive toxicity in male ratsEmerging drugs for malaria.Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position.Effect of disposition of mannich antimalarial agents on their pharmacology and toxicology.Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.Disturbances of potassium homeostasis in poisoning.Chloroquine poisoning: report of two cases.Hydroxychloroquine overdose: toxicokinetics and management.Suicidal chloroquine poisoning: report of two cases.Prevention of chloroquine absorption by activated charcoal.Full recovery after a chloroquine suicide attempt.Neurotoxic effects of chloroquine in vitro.The use of diazepam in chloroquine poisoning.Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes.Safety of computerized drug management: a case report.Methemoglobinemia due to quinine causing severe acute kidney injury in a child.Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells.A late presentation of ocular quinine toxicity managed with a combination of vasodilatory treatments.Inhibition of Kir4.1 potassium channels by quinacrine.Chloroquine and diazepam for her last sleep.Management of dapsone poisoning complicated by methaemoglobinaemia.
P2860
Q28325355-BCA47482-BC27-4A51-8BE1-4053F5714B46Q34346263-EB7B09FA-35E6-4131-A66D-21A421617C43Q34525606-D2FA3DC9-BC74-4805-9415-D8FF0ABA8E30Q34601493-7C86250A-C9A4-4D9C-8AE4-3C9C8B28AF3EQ35311711-2C9E18A2-3C7B-4375-9C3B-A5CD8B8BC9E5Q36006607-B099FF54-05F7-4316-88E4-11C32B0BC0CEQ36945007-15AACD0D-723E-46F8-8BBC-83F60D6EF5DFQ37035200-A026B3CC-C82D-422C-97F3-AF369362D126Q38027179-73A086A7-D17F-448F-B772-1EB73401EA05Q38099191-A8FE7A71-8B2B-4B2D-B1B0-CA9F54243DC4Q39558835-2138E182-657F-4522-9AB5-92C3F0FF30DBQ40437254-6F209D0A-606F-4398-8AC1-3F923C2B713DQ40457220-C7BDDA48-FDBA-4CAF-A26B-02CC194EE02CQ41921131-AA3CCB67-4490-4669-B64A-3FB79556A902Q41922460-6736CAB8-96AE-420B-BC9F-A1537854C012Q41934602-EAA60E56-FC4D-4341-8A38-D800CA37CE51Q41940545-6815AFC7-DFCF-4694-8696-9DB61C08697EQ41942657-C28D0ECB-89E2-4D91-A76B-896520BBA83EQ41942721-C3B9CC68-F173-4488-A3D3-BBCD007227F8Q41943144-D2357A5E-E849-4AF5-9267-A409609D7347Q42047527-45CC9CF8-081A-42EB-9F58-454050001CBAQ42538555-69F75B96-14D0-46C1-BBB0-2B7B1640C6D3Q43036477-955B29AB-0BFD-4428-BA44-34D0B8496E62Q44236552-6170BA8B-7010-4CD6-B116-2EFC8AA941E2Q45053186-7DE88301-0908-4A74-9133-62F7F2493094Q45054509-D24D8F7C-CB41-4A32-99B5-7E172678678BQ47990919-2522E893-9EE9-4E42-8C83-EE60B6F0E2E5Q50885999-918FFEB1-405A-4F15-B74F-D7827CBB0764
P2860
Clinical features and management of poisoning due to antimalarial drugs.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Clinical features and management of poisoning due to antimalarial drugs.
@en
Clinical features and management of poisoning due to antimalarial drugs.
@nl
type
label
Clinical features and management of poisoning due to antimalarial drugs.
@en
Clinical features and management of poisoning due to antimalarial drugs.
@nl
prefLabel
Clinical features and management of poisoning due to antimalarial drugs.
@en
Clinical features and management of poisoning due to antimalarial drugs.
@nl
P2093
P2860
P356
P1476
Clinical features and management of poisoning due to antimalarial drugs.
@en
P2093
J Kopferschmitt
P2860
P304
P356
10.1007/BF03259868
P577
1987-07-01T00:00:00Z